Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro

Interferons (IFN) have antiviral activity against many viruses, including SARS-CoV-2. A combination of IFN-a2b and the antioxidant taurine is widely used in the Russian Federation, and its antiviral activity has not been studied before. The aim of this study was to determine the antiviral activity o...

Full description

Saved in:
Bibliographic Details
Main Authors: N. P. Kartashova, A. V. Ivanina, E. A. Glubokova, I. N. Falynskova, A. A. Poromov, I. A. Leneva
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2022-12-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/954
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849244547367829504
author N. P. Kartashova
A. V. Ivanina
E. A. Glubokova
I. N. Falynskova
A. A. Poromov
I. A. Leneva
author_facet N. P. Kartashova
A. V. Ivanina
E. A. Glubokova
I. N. Falynskova
A. A. Poromov
I. A. Leneva
author_sort N. P. Kartashova
collection DOAJ
description Interferons (IFN) have antiviral activity against many viruses, including SARS-CoV-2. A combination of IFN-a2b and the antioxidant taurine is widely used in the Russian Federation, and its antiviral activity has not been studied before. The aim of this study was to determine the antiviral activity of interferon drugs, in combination with taurine and without it. The study included cytotoxicity and antiviral activity assays of IFN-a2b preparations, when stored according to the instructions at 2–8°C, and after 1 month storage at the temperature of 20–26°C in a pre-opened state. The combination of IFN alpha-2b with taurine has a higher antiviral activity compared to IFN alpha-2b mono-preparation by more than 25% at a «low» and 85% at a «high» multiplicity of infection. Selectivity index for combinations of IFN-a2b (50,000 IU/dose) + taurine (1 mg/ml) and IFN-a2b (10,000 IU/ml) + taurine (0.8 mg/ml) was more than 600 units, whereas for the IFN-a2b (10,000 IU/ml) it was 200 units. Antiviral activity does not change after one month at room temperature. The combination of interferon with taurine at high concentrations was less toxic than interferon. The results obtained demonstrate practicability of interferon alpha-2b and taurine combination use for treatment and prevention of COVID-19.
format Article
id doaj-art-5e1f33ca858a4d47b1e1a1acaae907b6
institution Kabale University
issn 0235-2990
language Russian
publishDate 2022-12-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-5e1f33ca858a4d47b1e1a1acaae907b62025-08-20T03:59:08ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902022-12-01679-10354110.37489/0235-2990-2022-67-9-10-35-41864Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitroN. P. Kartashova0A. V. Ivanina1E. A. Glubokova2I. N. Falynskova3A. A. Poromov4I. A. Leneva5Mechnikov Research Institute for Vaccines and SeraMechnikov Research Institute for Vaccines and SeraMechnikov Research Institute for Vaccines and SeraMechnikov Research Institute for Vaccines and SeraMechnikov Research Institute for Vaccines and Sera; The Peoples' Friendship University of Russia (RUDN University)Mechnikov Research Institute for Vaccines and SeraInterferons (IFN) have antiviral activity against many viruses, including SARS-CoV-2. A combination of IFN-a2b and the antioxidant taurine is widely used in the Russian Federation, and its antiviral activity has not been studied before. The aim of this study was to determine the antiviral activity of interferon drugs, in combination with taurine and without it. The study included cytotoxicity and antiviral activity assays of IFN-a2b preparations, when stored according to the instructions at 2–8°C, and after 1 month storage at the temperature of 20–26°C in a pre-opened state. The combination of IFN alpha-2b with taurine has a higher antiviral activity compared to IFN alpha-2b mono-preparation by more than 25% at a «low» and 85% at a «high» multiplicity of infection. Selectivity index for combinations of IFN-a2b (50,000 IU/dose) + taurine (1 mg/ml) and IFN-a2b (10,000 IU/ml) + taurine (0.8 mg/ml) was more than 600 units, whereas for the IFN-a2b (10,000 IU/ml) it was 200 units. Antiviral activity does not change after one month at room temperature. The combination of interferon with taurine at high concentrations was less toxic than interferon. The results obtained demonstrate practicability of interferon alpha-2b and taurine combination use for treatment and prevention of COVID-19.https://www.antibiotics-chemotherapy.ru/jour/article/view/954hydrogen peroxymonosulfateampicillinspectrophotometryvoltammetryredox titration
spellingShingle N. P. Kartashova
A. V. Ivanina
E. A. Glubokova
I. N. Falynskova
A. A. Poromov
I. A. Leneva
Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro
Антибиотики и Химиотерапия
hydrogen peroxymonosulfate
ampicillin
spectrophotometry
voltammetry
redox titration
title Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro
title_full Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro
title_fullStr Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro
title_full_unstemmed Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro
title_short Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro
title_sort antiviral activity of interferon alpha 2b and taurine combination against sars cov 2 in vitro
topic hydrogen peroxymonosulfate
ampicillin
spectrophotometry
voltammetry
redox titration
url https://www.antibiotics-chemotherapy.ru/jour/article/view/954
work_keys_str_mv AT npkartashova antiviralactivityofinterferonalpha2bandtaurinecombinationagainstsarscov2invitro
AT avivanina antiviralactivityofinterferonalpha2bandtaurinecombinationagainstsarscov2invitro
AT eaglubokova antiviralactivityofinterferonalpha2bandtaurinecombinationagainstsarscov2invitro
AT infalynskova antiviralactivityofinterferonalpha2bandtaurinecombinationagainstsarscov2invitro
AT aaporomov antiviralactivityofinterferonalpha2bandtaurinecombinationagainstsarscov2invitro
AT ialeneva antiviralactivityofinterferonalpha2bandtaurinecombinationagainstsarscov2invitro